2 citations
,
November 2020 in “Chirurgia” Scalp reconstruction is complex and aims to restore function and appearance after damage.
1 citations
,
January 2025 in “ARC Journal of Dermatology”
1 citations
,
January 2022 in “Monaldi archives for chest disease” After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.
1 citations
,
August 2021 in “Internal Medicine Journal” After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.
1 citations
,
June 2014 in “L Endocrinologo” Finasteride can cause lasting sexual and mood issues even after stopping the drug.
June 2026 in “RCMOS - Revista Científica Multidisciplinar O Saber” Rosemary oil may help hair growth like 2% minoxidil.
March 2026 in “Jurnal Biomedika dan Kesehatan” No significant link was found between the rs1998076 gene variant and hair loss in Indonesians.
March 2026 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” Using dutasteride during hair transplants improves results and reduces hair loss.
March 2026 in “Editora Pasteur eBooks” Hair health is affected by various conditions and requires personalized treatment.
March 2026 in “International Society of Hair Restoration Surgery” Exosome therapies may help with hair growth and are generally safe, but more research is needed.
January 2026 in “Surgical & Cosmetic Dermatology” January 2026 in “Endocrinology”
October 2025 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” Dengue can cause anxiety, depression, and other mental health issues.
CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.
May 2025 in “International Society of Hair Restoration Surgery” Exosomes show promise for promoting hair growth and treating scalp disorders.
January 2025 in “Journal of Biosciences and Medicines” Careful patient selection is crucial for safe and effective fractional CO2 laser therapy.
Low-dose oral minoxidil is effective and generally safe for treating hair loss in women.
June 2024 in “International Journal of Health Science” Current treatments for androgenetic alopecia are often ineffective and have side effects, needing better options.
April 2024 in “Journal of endocrinological investigation” Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.
February 2024 in “International journal of medical science and clinical research studies” CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.
January 2024 in “ACTA SCIENTIAE VETERINARIAE” An epidermoid cyst in a dog's mammary gland is rare and benign.
Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.
January 2023 in “Editora Enterprising eBooks” Low education and income can lead to not following high blood pressure treatment.
November 2022 in “JAAD case reports” A man with skin and hair symptoms improved partially with specific treatment.
October 2022 in “Respiratory Medicine” Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.
April 2021 in “International journal of advanced research” COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.
November 2020 in “Dermatologic Therapy” August 2016 in “The journal of investigative dermatology/Journal of investigative dermatology” Different types of skin cells create unique support structures that can affect skin cell growth and could help in skin repair.
September 2009 in “European Urology Supplements” Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.
September 2009 in “European Urology Supplements” IGRT resulted in lower acute toxicity for stage III prostate cancer patients.